Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Livingstone Health HoldingsSGX:PRH EV-to-EBITDA is 7.53 as of Sep. 08, 2026, which is 73% above its 10-year median of 4.36. The stock has 2 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Livingstone Health Holdings ranks better than 68.95% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Livingstone Health Holdings's enterprise value is S$16.20 Mil.
Livingstone Health Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was S$2.15 Mil. Therefore, Livingstone Health Holdings's EV-to-EBITDA for today is 7.53.
The historical rank and industry rank for Livingstone Health Holdings's EV-to-EBITDA or its related term are showing as below:
SGX:PRH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -153.64 Med: 4.36 Max: 16.01
Current: 7.53
During the past 13 years, the highest EV-to-EBITDA of Livingstone Health Holdings was 16.01. The lowest was -153.64. And the median was 4.36.
SGX:PRH's EV-to-EBITDA is ranked better than 68.95% of 512
companies
in the Healthcare Providers & Services industry
Industry Median: 10.555
vs SGX:PRH: 7.53
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Livingstone Health Holdings (SGX:PRH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Livingstone Health Holdings's PE Ratio (TTM) for today is calculated as:
Livingstone Health Holdings's share price for today is S$0.025.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Livingstone Health Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was S$0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Livingstone Health Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Livingstone Health Holdings EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Livingstone Health Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Livingstone Health Holdings's EV-to-EBITDA falls into.
Livingstone Health Holdings's current Enterprise Value is S$16.20 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Livingstone Health Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was S$2.15 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Livingstone Health Holdings (SGX:PRH) has a EV-to-EBITDA of 7.53 as of Sep. 08, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Livingstone Health Holdings. This is 73% above median its historical median of 4.36. According to the industry distribution chart, Livingstone Health Holdings ranks #159 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 31.1%.
Is Livingstone Health Holdings' EV-to-EBITDA too high?
Livingstone Health Holdings' current EV-to-EBITDA of 7.53 is 73% above median its 10-year median of 4.36. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.56. Livingstone Health Holdings' value of 7.53 is 28.7% below this industry median. Based on the distribution chart, Livingstone Health Holdings ranks #159 out of 512 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Livingstone Health Holdings' EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Livingstone Health Holdings ranks #159 out of 512 companies for EV-to-EBITDA. This puts Livingstone Health Holdings in the upper half of its industry. The industry median EV-to-EBITDA is 10.56. Livingstone Health Holdings' value of 7.53 is 28.7% below this benchmark. While the company's 10-year median is 4.36 vs. the industry median of 10.56, Livingstone Health Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.56, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Livingstone Health Holdings's current EV-to-EBITDA of 7.53 is 28.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Livingstone Health Holdings. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Livingstone Health Holdings's current EV-to-EBITDA is 7.53, which is 73% above median its own 10-year median of 4.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Livingstone Health Holdings stock overvalued right now?
Based on GuruFocus' analysis, Livingstone Health Holdings (SGX:PRH) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.02, compared to a current price of S$0.03 — trading 25% above its estimated fair value. The current EV-to-EBITDA is 7.53, which is 73% above median its 10-year median of 4.36 and 28.7% below the Healthcare Providers & Services industry median of 10.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Livingstone Health Holdings (SGX:PRH), the current EV-to-EBITDA is 7.53 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Livingstone Health Holdings Ltd through its subsidiaries, is engaged in providing medical treatment and consultancy services. It is engaged in providing healthcare facilities through its clinics. The services offered by the company comprise Orthopaedic, Aesthetics and Wellness, Pain and Anaesthesiology, Dermatology, and Family Medicine among others. The company's reportable segments are Specialist Healthcare, Primary Healthcare, and Others. The majority of its revenue is generated from the Specialist Healthcare segment which includes services provided by healthcare professionals who focus on a specific field of medicine such as Dermatology, Anaesthesiology and Pain Management, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:PRH has been successfully added to your 
